Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
39.60
-0.02 (-0.04%)
At close: May 8, 2026, 4:00 PM EDT
39.59
0.00 (-0.01%)
After-hours: May 8, 2026, 5:40 PM EDT
Centessa Pharmaceuticals Employees
Centessa Pharmaceuticals had 118 employees as of December 31, 2025. The number of employees increased by 41 or 53.25% compared to the previous year.
Employees
118
Change
41
Growth
53.25%
Revenue / Employee
n/a
Profits / Employee
-$2,124,051
Market Cap
6.13B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 118 | 41 | 53.25% |
| Sep 30, 2025 | 114 | 39 | 52.00% |
| Jun 30, 2025 | 98 | 26 | 36.11% |
| Mar 31, 2025 | 86 | 9 | 11.69% |
| Dec 31, 2024 | 77 | 1 | 1.32% |
| Sep 30, 2024 | 75 | 0 | - |
| Jun 30, 2024 | 72 | 8 | 12.50% |
| Mar 31, 2024 | 77 | -5 | -6.10% |
| Dec 31, 2023 | 76 | -7 | -8.43% |
| Sep 30, 2023 | 75 | 7 | 10.29% |
| Jun 30, 2023 | 64 | -4 | -5.88% |
| Mar 31, 2023 | 82 | -8 | -8.89% |
| Dec 31, 2022 | 83 | -7 | -7.78% |
| Sep 30, 2022 | 68 | -2 | -2.86% |
| Jun 30, 2022 | 68 | 23 | 51.11% |
| Mar 31, 2022 | 90 | 45 | 100.00% |
| Dec 31, 2021 | 90 | - | - |
| Sep 30, 2021 | 70 | - | - |
| Jun 30, 2021 | 45 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Rhythm Pharmaceuticals | 414 |
| TG Therapeutics | 399 |
| Mirum Pharmaceuticals | 372 |
| Apogee Therapeutics | 261 |
| Cogent Biosciences | 258 |
| Celcuity | 155 |
| CG Oncology | 142 |
CNTA News
- 20 days ago - Centessa downgraded to Equal Weight from Overweight at Wells Fargo - TheFly
- 27 days ago - Centessa downgraded to Hold from Buy at Truist - TheFly
- 5 weeks ago - Centessa downgraded to Neutral from Buy at Guggenheim - TheFly
- 5 weeks ago - Centessa downgraded to Market Perform from Outperform at LifeSci Capital - TheFly
- 5 weeks ago - Centessa downgraded to Market Perform from Outperform at Leerink - TheFly
- 5 weeks ago - Nxera Pharma's Partner Centessa Pharmaceuticals to be Acquired by Lilly - GlobeNewsWire
- 5 weeks ago - Alkermes jumps 15% on renewed biotech M&A buzz, says Leerink - TheFly
- 5 weeks ago - Centessa acquisition ‘may help rouse’ Alkermes shares, says RBC Capital - TheFly